References
- Tinkanen H, Blauer, M, Laippala P, et al. Prognostic factors in controlled ovarian hyperstimulation. Fertil Steril 1999;72:932–6
- Navot D, Rosenwaks S, Margolioth EJ. Prognostic assessment of female fecundity. Lancet 1989;2:645–7
- Scott RT, Hoffmann GE. Prognostic assessment of ovarian reserve. Fertil Steril 1994;62:1–11
- Seifer DB, Lambert-Messerlian G, Hogan JW, et al. Day 3 serum inhibin B is predictive of assisted repro-ductive technologies outcome. Fertil Steril 1997;67: 110–14
- Vale W, Rivier C, Hsueh, A, et al. Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 1998;44:1
- Lockwood GM, Muttukrishna S, Gro o me NP. Circulating inhibins and activin A during GnRH analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in vitro fertilization embryo transfer. Clin Endocrinol 1996; 45:741–8
- Eldar-Geva T, Robertson DM, Cahir N. Relation-ship between serum inhibin A and B and ovarian follicle development after a daily fixed dose adminis-tration of recombinant follicle-stimulating hormone. J Clin Endocrinol 2000;85:607–13
- Eldar-Geva T, Margalioth EJ, Ben-Chetrit A. Serum inhibin B levels measured early during FSH adminis-tration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum Reprod 2002;17:2331–7
- Seifer DB, Scott RT, Bergh PA, et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril 1999;72: 63–5
- Hoffmann GE, Danforth DR, Seifer DB. Inhibin B: the physiological basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 1998;69:474–7
- Penarrubia J, Balasch, J, Fabregues F, et al. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone ago nist—go nado trophin treatment. Hum Reprod 2000; 15:1499–504
- Creus M, Penarrubia J, Fabregues F, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 2000; 15:2341–6
- Corson SL, Gutmann J, Batzer FR, et al. Inhibin B as a test of ovarian reserve for infertile women. Hum Reprod 1999;14:2818–21
- Hall JE, Welt CK, Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted repro-duction but are less useful at predicting outcome. Hum Reprod 1999;14:409–15
- Ravhon A, Lavery S, Michael S, et al. Dynamic assays of inhibin B and estradiol following buserelin acetate administration as predictors of ovarian response in IVF. Hum Reprod 2000;15:2297–301
- Burns WN, Oktay KH, Rao Tekmal R, et al. Dimin-ished a-inhibin messenger ribonucleic acid in in vitro fertilization—embryo transfer poor responders reflects declining follile reserve. Fertil Steril 1996;65:394–9
- Phelps, JY, Levine AS, Hickman TN. Day 4 estradiol levels predict pregnancy success in women under-going controlled ovarian hyperstimulation for IVF. Fertil Steril 1998;69:1015–19
- Fanchin R, Ziegler D, Olivennes F, et al. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in vitro fertilization. Hum Reprod 1994;9:1607–11
- Dzik A, Lambert-Messerlian G, Izzo VM, et al. Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertil Steril 2000;74:1114–17
- Galtier-Dereure F, DeBouard V, Picot MC. Ovarian reserve test with the gonadotrophin releasing hormone agonist buserelin: correlation with in vitro fertilization outcome. Hum Reprod 1996;11:1393–8